Sign in

NCT03484702CompletedPhase 2

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

A Phase 2, Single-arm, Multi-center Trial to Determine the Efficacy and Safety of JCAR017 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or With Other Aggressive B-Cell Malignancies

Source: ClinicalTrials.gov · Last updated 27 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to evaluate the efficacy and safety of JCAR017 in participants with aggressive B-cell non-Hodgkin lymphoma (B-NHL)

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
113 (actual)
First submitted
26 Mar 2018
Start date
5 Jun 2018
Primary completion date
15 Dec 2023
Lead sponsor
Celgene
NCT number
NCT03484702
EudraCT number
2017-000106-38

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 113
  • From 5 Jun 2018 to the primary completion date, 15 Dec 2023
  • 20 sites in 11 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Received previous CD19-targeted therapy

Other illness

  • Progressive vascular tumor invasion, thrombosis, or embolism
    • Other protocol-defined inclusion/exclusion criteria apply

Age

  • Prior history of malignancies, other than aggressive relapsed/refractory Non-Hodgkin Lymphoma, unless the participant has been in remission for ≥ 2 years with the exception of non-invasive malignancies

Who the study is looking for

  • Histological confirmation of diagnosis at last relapse
  • Adequate organ function
  • Adequate vascular access for leukapheresis procedure

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (20)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Local Institution - 101
Coordinator of this site? Confirm its status
ViennaAustriaUnknown status
Local Institution - 351
Coordinator of this site? Confirm its status
GhentBelgiumUnknown status
Local Institution - 251
Coordinator of this site? Confirm its status
BernSwitzerlandUnknown status
Local Institution - 151
Coordinator of this site? Confirm its status
CologneGermanyUnknown status
Local Institution - 152
Coordinator of this site? Confirm its status
DresdenGermanyUnknown status
Local Institution - 155
Coordinator of this site? Confirm its status
HeidelbergGermanyUnknown status
Local Institution - 154
Coordinator of this site? Confirm its status
MünchenGermanyUnknown status
Local Institution - 153
Coordinator of this site? Confirm its status
UlmGermanyUnknown status
Local Institution - 451
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Local Institution - 551
Coordinator of this site? Confirm its status
HelsinkiFinlandUnknown status
Local Institution - 202
Coordinator of this site? Confirm its status
LilleFranceUnknown status
Local Institution - 203
Coordinator of this site? Confirm its status
ParisFranceUnknown status
Local Institution - 201
Coordinator of this site? Confirm its status
Pierre-BéniteFranceUnknown status
Local Institution - 501
Coordinator of this site? Confirm its status
LondonUnited KingdomUnknown status
Local Institution - 502
Coordinator of this site? Confirm its status
ManchesterUnited KingdomUnknown status
Local Institution - 402
Coordinator of this site? Confirm its status
MilanItalyUnknown status
Local Institution - 401
Coordinator of this site? Confirm its status
TorinoItalyUnknown status
Local Institution - 601
Coordinator of this site? Confirm its status
Chuo-kuJapanUnknown status
Local Institution - 602
Coordinator of this site? Confirm its status
Minato-kuJapanUnknown status
Local Institution - 301
Coordinator of this site? Confirm its status
RotterdamNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.